Table 1 Patient characteristics.

From: Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas

Numbers

Patients = 60

Controls = 32

Diagnosis

primary GBM IDH wildtype (n)

50 (83%)

 

recurrent GBM IDH wildtype (n)

10 (17%)

 

Sex

male (n)

34 (57%)

18 (56%)

female (n)

26 (43%)

14 (44%)

Median age

years (range)

61 (41–83)

61 (41–81)

Resection status

complete

35 (58%)

 

incomplete

25 (42%)

 

Steroids

received

38 (63%)

 

not received

22 (37%)

 

MGMT status

methylated

26 (43%)

 

unmethylated

34 (57%)

 
Back to article page